Akebia Therapeutics Stock Forecast

Sell candidate since Oct 29, 2025 Loss -16.19%

The Akebia Therapeutics stock price gained 5.39% on the last trading day (Monday, 17th Nov 2025), rising from $1.67 to $1.76. During the last trading day the stock fluctuated 9.88% from a day low at $1.67 to a day high of $1.84. The price has been going up and down for this period, and there has been a -16.98% loss for the last 2 weeks. Volume fell on the last day by -8 million shares and in total, 6 million shares were bought and sold for approximately $10.36 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.58 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -27.89% during the next 3 months and, with a 90% probability hold a price between $1.14 and $2.10 at the end of this 3-month period.

AKBA Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, November 10, 2025, and so far it has risen 5.39%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akebia Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.79 and $2.53. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Akebia Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.67. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.165 between high and low, or 9.88%. For the last week, the stock has had daily average volatility of 7.99%.

Akebia Therapeutics is oversold on RSI14 (20). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKBA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Akebia Therapeutics to open at $1.76, and during the day (based on 14 day Average True Range), to move between $1.67 and $1.85, which gives a possible trading interval of +/-$0.177 (+/-10.58%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 10.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.67 (5.11%) than the resistance at $2.09 (18.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akebia Therapeutics stock A Buy?

Akebia Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.444 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $1.76 ( 0.284%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk